{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:35:47Z","timestamp":1792787747425,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastrointestinal Endoscopy Clinics of North America"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.giec.2019.12.005","type":"journal-article","created":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T13:45:22Z","timestamp":1578923122000},"page":"239-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Proton Pump Inhibitors"],"prefix":"10.1016","volume":"30","author":[{"given":"Felice","family":"Schnoll-Sussman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Niec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip O.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.giec.2019.12.005_bib1","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ajg.2012.444","article-title":"Guidelines for the diagnosis and management of gastroesophageal reflux disease","volume":"108","author":"Katz","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.giec.2019.12.005_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12916-016-0718-z","article-title":"Effective and safe proton pump inhibitor therapy in acid-related diseases\u2013\u2013a position paper addressing benefits and potential harms of acid suppression","volume":"14","author":"Scarpignato","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.giec.2019.12.005_bib3","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/apt.14895","article-title":"Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett\u2019s oesophagus: a nested case-control study in US male veterans","volume":"48","author":"Tan","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.giec.2019.12.005_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/j.gastro.2017.04.047","article-title":"Complications of proton pump inhibitor therapy","volume":"153","author":"Vaezi","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.giec.2019.12.005_bib5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.14309\/ajg.0000000000000061","article-title":"Patient\u2019s perceptions of proton pump inhibitor risks and attempts at discontinuation: a national survey","volume":"114","author":"Kurlander","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.giec.2019.12.005_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.14740\/gr944w","article-title":"Internist\u2019s perceptions of proton pump inhibitor adverse effects and impact on prescribing practices: results of a nationwide survey","volume":"11","author":"Kurlander","year":"2018","journal-title":"Gastroenterology Res"},{"issue":"suppl","key":"10.1016\/j.giec.2019.12.005_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0016-5085(00)70004-7","article-title":"Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome","volume":"118","author":"Wolfe","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.giec.2019.12.005_bib8","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1046\/j.1365-2036.1998.00426.x","article-title":"Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40\u00a0mg daily","volume":"12","author":"Hatlebakk","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.giec.2019.12.005_bib9","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0002-9270(02)04533-1","article-title":"Esomeprazole 40\u00a0mg twice daily maintains intragastric pH\u00a0> 4 more than 80% of a 24-hour time period","volume":"97","author":"Katz","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.giec.2019.12.005_bib10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1517\/17425255.2012.657626","article-title":"Cytochrome P450 variations in different ethnic populations","volume":"8","author":"McGraw","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"8","key":"10.1016\/j.giec.2019.12.005_bib11","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/dmd.32.8.821","article-title":"Comparison of inhibitory effects of the proton pump-inhbiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities","volume":"32","author":"Li","year":"2004","journal-title":"Drug Metab Dispos"},{"issue":"14","key":"10.1016\/j.giec.2019.12.005_bib12","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.jacc.2011.12.024","article-title":"A\u00a0randomized, 2-period, crossover design study to assess the effects of dexlansoprazole, lansoprazole, esomeprazole, and omeprazole on the steady-state pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers","volume":"59","author":"Frelinger","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.giec.2019.12.005_bib13","doi-asserted-by":"crossref","first-page":"e9638","DOI":"10.1097\/MD.0000000000009638","article-title":"Influence of proton pump inhibitors on clinical outcomes in coronary heart disease patients receiving aspirin and clopidogrel: a meta-analysis","volume":"97","author":"Hu","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.giec.2019.12.005_bib14","doi-asserted-by":"crossref","first-page":"e000248","DOI":"10.1136\/openhrt-2015-000248","article-title":"Incidence of cardiovascular events and gastrointestinal bleeding in patients receiving clopidogrel with and without proton pump inhibitors: an updated meta-analysis","volume":"2","author":"Cardoso","year":"2015","journal-title":"Open Heart"},{"issue":"3","key":"10.1016\/j.giec.2019.12.005_bib15","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1053\/j.gastro.2010.11.056","article-title":"Esomeprazole with clopidogrel reduces peptic ulcer recurrence, compared with clopidogrel alone, in patients with atherosclerosis","volume":"140","author":"Hsu","year":"2011","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.giec.2019.12.005_bib16","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/CIRCULATIONAHA.113.003602","article-title":"Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine","volume":"128","author":"Ghebremariam","year":"2013","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.giec.2019.12.005_bib17","doi-asserted-by":"crossref","first-page":"e0124653","DOI":"10.1371\/journal.pone.0124653","article-title":"Proton pump inhibitor usage and the risk of myocardial infarction in the general population","volume":"10","author":"Shah","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.giec.2019.12.005_bib18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/1358863X14568444","article-title":"Proton pump inhibitors and vascular function: a prospective cross-over pilot study","volume":"20","author":"Ghebremariam","year":"2015","journal-title":"Vasc Med"},{"issue":"6","key":"10.1016\/j.giec.2019.12.005_bib19","doi-asserted-by":"crossref","first-page":"378","DOI":"10.7326\/0003-4819-153-6-201009210-00005","article-title":"Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study","volume":"153","author":"Charlot","year":"2010","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.giec.2019.12.005_bib20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00228-014-1779-6","article-title":"Revising the link between proton-pump inhibitors and risk of acute myocardial infarction - a case-crossover analysis","volume":"71","author":"Turkiewicz","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.giec.2019.12.005_bib21","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ijcard.2014.09.036","article-title":"Proton pump inhibitor use represents an independent risk factor for myocardial infarction","volume":"177","author":"Shih","year":"2014","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.giec.2019.12.005_bib22","first-page":"402","article-title":"Effects of clopidogrel and proton pump inhibitors on cardiovascular events in patients with type 2 diabetes mellitus after bare metal stent implantation: a nationwide cohort study","volume":"35","author":"Lee","year":"2019","journal-title":"Acta Cardiol Sin"},{"issue":"8","key":"10.1016\/j.giec.2019.12.005_bib23","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/apt.14955","article-title":"Systematic review with meta-analysis: risk of adverse cardiovascular events with proton pump inhibitors independent of clopidogrel","volume":"48","author":"Batchelor","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.giec.2019.12.005_bib24","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.hlc.2017.10.020","article-title":"Proton pump inhibitors and cardiovascular events: a systematic review","volume":"27","author":"Shiraev","year":"2018","journal-title":"Heart Lung Circ"},{"issue":"20","key":"10.1016\/j.giec.2019.12.005_bib25","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1007964","article-title":"Clopidogrel with or without omeprazole in coronary artery disease","volume":"363","author":"Bhatt","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.giec.2019.12.005_bib26","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00406-014-0554-0","article-title":"Risk of dementia in elderly patients with the use of proton pump inhibitors","volume":"265","author":"Haenisch","year":"2015","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"3","key":"10.1016\/j.giec.2019.12.005_bib27","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1053\/j.gastro.2019.05.056","article-title":"Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin","volume":"157","author":"Moayyedi","year":"2019","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.giec.2019.12.005_bib28","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamaneurol.2015.4791","article-title":"Association of proton pump inhibitors with risk of dementia: a pharmacoepidemiological claims data analysis","volume":"73","author":"Gomm","year":"2016","journal-title":"JAMA Neurol"},{"issue":"5","key":"10.1016\/j.giec.2019.12.005_bib29","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.cgh.2018.01.034","article-title":"Lack of association between proton pump inhibitor use and cognitive decline","volume":"16","author":"Wod","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.giec.2019.12.005_bib30","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1053\/j.gastro.2017.06.061","article-title":"Association between proton pump inhibitor use and cognitive function in women","volume":"153","author":"Lochhead","year":"2017","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.giec.2019.12.005_bib31","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1038\/ajg.2017.196","article-title":"No association between proton pump inhibitor use and risk of Alzheimer's disease","volume":"112","author":"Taipale","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.giec.2019.12.005_bib32","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jamainternmed.2015.7193","article-title":"Proton pump inhibitor use and the risk of chronic kidney disease","volume":"176","author":"Larazus","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.giec.2019.12.005_bib33","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1681\/ASN.2015121377","article-title":"Proton pump inhibitors and risk of incident CKD and progression to ESRD","volume":"27","author":"Xie","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.giec.2019.12.005_bib34","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.2147\/DDDT.S130568","article-title":"Proton-pump inhibitors use, and risk of acute kidney injury: a meta-analysis of observational studies","volume":"11","author":"Yang","year":"2017","journal-title":"Drug Des Devel Ther"},{"issue":"3","key":"10.1016\/j.giec.2019.12.005_bib35","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1053\/j.gastro.2017.05.046","article-title":"Association between proton pump inhibitor use and risk of progression of chronic kidney disease","volume":"153","author":"Klatte","year":"2017","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.giec.2019.12.005_bib36","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1007\/s10620-017-4725-5","article-title":"Associations of proton-pump inhibitors and H2 receptor antagonists with chronic kidney disease: a meta-analysis","volume":"62","author":"Wijarnpreecha","year":"2017","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.giec.2019.12.005_bib37","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0002-9343(98)00087-4","article-title":"Effect of long-term gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome","volume":"104","author":"Termanini","year":"1998","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.giec.2019.12.005_bib38","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2036.2008.03601.x","article-title":"Long-term use of proton pump inhibitors and vitamin B12 status in elderly individuals","volume":"27","author":"den Elzen","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.giec.2019.12.005_bib39","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3889\/oamjms.2018.142","article-title":"Proton pump inhibitors intake and iron and vitamin B12 status: a prospective comparative study with a follow up of 12\u00a0months","volume":"6","author":"Qorraj-Bytyqi","year":"2018","journal-title":"Open Access Maced J Med Sci"},{"issue":"17","key":"10.1016\/j.giec.2019.12.005_bib40","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMc066308","article-title":"Proton-pump inhibitors and hypomagnesemic hypoparathyroidism","volume":"355","author":"Epstein","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.giec.2019.12.005_bib41","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1053\/j.ajkd.2013.02.373","article-title":"Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control study","volume":"62","author":"Koulouridis","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.giec.2019.12.005_bib42","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/apt.13194","article-title":"Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies","volume":"41","author":"Attwood","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.giec.2019.12.005_bib43","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.amjmed.2005.02.007","article-title":"Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial","volume":"118","author":"O'Connell","year":"2005","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.giec.2019.12.005_bib44","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1152\/physrev.00015.2012","article-title":"Gastric acid, calcium absorption, and their impact on bone health","volume":"93","author":"Kopic","year":"2013","journal-title":"Physiol Rev"},{"issue":"10","key":"10.1016\/j.giec.2019.12.005_bib45","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1002\/jbmr.108","article-title":"Inhibiting gastric acid production does not affect intestinal calcium absorption in young, healthy individuals: a randomized, crossover, controlled clinical trial","volume":"25","author":"Wright","year":"2010","journal-title":"J\u00a0Bone Miner Res"},{"issue":"24","key":"10.1016\/j.giec.2019.12.005_bib46","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.296.24.2947","article-title":"Long-term proton pump inhibitor therapy and risk of hip fracture","volume":"296","author":"Yang","year":"2006","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.giec.2019.12.005_bib47","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1053\/j.gastro.2010.03.055","article-title":"Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients","volume":"139","author":"Corley","year":"2010","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.giec.2019.12.005_bib48","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/archinternmed.2010.94","article-title":"Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative","volume":"170","author":"Gray","year":"2010","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1016\/j.giec.2019.12.005_bib49","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/ajg.2011.113","article-title":"Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies","volume":"106","author":"Ngamruengphong","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.giec.2019.12.005_bib50","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1053\/j.gastro.2009.11.014","article-title":"Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss","volume":"138","author":"Targownik","year":"2010","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.giec.2019.12.005_bib51","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ajg.2016.481","article-title":"Long-term proton pump inhibitor use is not associated with changes in bone strength and structure","volume":"112","author":"Targownik","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.giec.2019.12.005_bib52","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1053\/j.gastro.2018.11.023","article-title":"Dexlansoprazole and esomeprazole do not affect bone homeostasis in healthy postmenopausal women","volume":"156","author":"Hansen","year":"2019","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.giec.2019.12.005_bib53","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/j.1572-0241.2007.01275.x","article-title":"Systematic review of the risk of enteric infection in patients taking acid suppression","volume":"102","author":"Leonard","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.giec.2019.12.005_bib54","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1017\/S0950268805005406","article-title":"Risk factors for Salmonella enteritidis and Typhimurium (DT104 and non-DT104) infections in the Netherlands: predominant roles for raw eggs in enteritidis and sandboxes in Typhimurium infections","volume":"134","author":"Doorduyn","year":"2006","journal-title":"Epidemiol Infect"},{"issue":"5","key":"10.1016\/j.giec.2019.12.005_bib55","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1017\/S0950268815002332","article-title":"Association between use of proton pump inhibitors and non-typhoidal salmonellosis identified following investigation into an outbreak of Salmonella Mikawasima in the UK, 2013","volume":"144","author":"Freeman","year":"2015","journal-title":"Epidemiol Infect"},{"issue":"10","key":"10.1016\/j.giec.2019.12.005_bib56","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1017\/S095026881000052X","article-title":"Risk factors for indigenous Campylobacter jejuni and Campylobacter coli infections in the Netherlands: a case-control study","volume":"138","author":"Doorduyn","year":"2010","journal-title":"Epidemiol Infect"},{"issue":"1","key":"10.1016\/j.giec.2019.12.005_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM197107012850101","article-title":"Pathogenesis of Escherichia coli diarrhea","volume":"285","author":"DuPont","year":"1971","journal-title":"N\u00a0Engl J Med"},{"issue":"11\u201312","key":"10.1016\/j.giec.2019.12.005_bib58","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1365-2036.2011.04874.x","article-title":"Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection","volume":"34","author":"Bavishi","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.giec.2019.12.005_bib59","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1128\/CMR.00052-05","article-title":"Prevention and self-treatment of traveler's diarrhea","volume":"19","author":"Diemert","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.giec.2019.12.005_bib60","first-page":"119","article-title":"Prevention and treatment of traveler's diarrhea","volume":"60","author":"Juckett","year":"1999","journal-title":"Am Fam Physician"},{"issue":"11","key":"10.1016\/j.giec.2019.12.005_bib61","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/apt.13199","article-title":"Systematic review with meta-analysis: post-infectious irritable bowel syndrome after travellers' diarrhoea","volume":"41","author":"Schwille-Kiuntke","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.giec.2019.12.005_bib62","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1365-2036.2008.03924.x","article-title":"Proton pump inhibitors increase significantly the risk of Clostridium difficile infection in a low-endemicity, non-outbreak hospital setting","volume":"29","author":"Dalton","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.giec.2019.12.005_bib63","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/ajg.2012.179","article-title":"Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis","volume":"107","author":"Janarthanan","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.giec.2019.12.005_bib64","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/ajg.2015.22","article-title":"Colonization with toxinogenic C.\u00a0difficile upon hospital admission, and risk of infection: a systematic review and meta-analysis","volume":"110","author":"Zacharioudakis","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.giec.2019.12.005_bib65","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/2049-2618-2-42","article-title":"Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility","volume":"2","author":"Seto","year":"2014","journal-title":"Microbiome"},{"issue":"8","key":"10.1016\/j.giec.2019.12.005_bib66","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1128\/AAC.01443-06","article-title":"Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: a potential mechanism to explain the association between proton pump inhibitors and C.\u00a0difficile-associated diarrhea?","volume":"51","author":"Jump","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.giec.2019.12.005_bib67","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/jamainternmed.2017.0212","article-title":"Association of gastric acid suppression with recurrent clostridium difficile infection: a systematic review and meta-analysis","volume":"177","author":"Tariq","year":"2017","journal-title":"JAMA Intern Med"}],"container-title":["Gastrointestinal Endoscopy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052515719301503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052515719301503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T07:20:09Z","timestamp":1760944809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052515719301503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S1052515719301503"],"URL":"https:\/\/doi.org\/10.1016\/j.giec.2019.12.005","relation":{},"ISSN":["1052-5157"],"issn-type":[{"value":"1052-5157","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proton Pump Inhibitors","name":"articletitle","label":"Article Title"},{"value":"Gastrointestinal Endoscopy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.giec.2019.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}